Search
Now showing items 1-5 of 5
Dramatic response to catumaxomab treatment for malign ascites related to renal cell carcinoma with sarcomotoid differentiation.
(Lippincott, Williams & Wilkins, 2014)
Refractory malignant ascites (MA) is a common complication in cancer patients. Renal cell carcinoma
(RCC) is rarely present with peritoneal ascites, which is commonly associated with carcinomas of the
gastrointestinal ...
The clinical and pathological features of 133 colorectal cancer patients with brain metastasis: a multicenter retrospective analysis of the Gastrointestinal Tumors Working Committee of the Turkish Oncology Group (TOG)
(Springer Verlag, 2014)
Brain metastasis in colorectal cancer is highly rare. In the present study, we aimed to determine the frequency of brain metastasis in colorectal cancer patients and to establish prognostic characteristics of colorectal ...
Tracheomediastinal fistula in a patient with lung adenocarcinoma and its treatment with argon plasma coagulation: a case report.
(Lippincott, Williams & Wilkins, 2014)
Tracheomediastinal fistula is a rare complication that occurs during the course of lung cancer. The fistula connects the airways to the mediastinum and is often associated with lymphoma. Clinical data on tracheomediastinal ...
Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group
(Springer Verlag, 2014)
Non-small cell lung cancer (NSCLC) is one of the most common cancers. Most of the patients are inoperable at the time of diagnosis, and the prognosis is poor. Many prognostic factors have been identified in prior studies. ...
Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: A pilot study
(Spandidos Publications, 2014)
The expression of epidermal growth factor receptor (EGFR) has been linked to clinical outcome in several solid tumors. However, the clinical significance of EGFR (c-erbB1) in gastric cancer remains unclear. The present ...